Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net sales	$ 2,151	$ 2,052	$ 6,553	$ 6,319
Cost of sales	682	655	2,125	2,036
Gross profit	1,469	1,397	4,428	4,283
Research, development and engineering expenses	136	114	397	342
Selling, general and administrative expenses	1,136	791	3,067	2,433
Intangible asset amortization	34	30	102	92
Restructuring Charges, Selling, General and Administrative	13	12	36	45
Total operating expenses	1,319	947	3,602	2,912
Operating income	150	450	826	1,371
Other income (expense), net	(13)	(6)	(45)	(24)
Earnings before income taxes	137	444	781	1,347
Income taxes	34	91	161	319
Net earnings	$ 103	$ 353	$ 620	$ 1,028
Net earnings per share of common stock:
Basic net earnings per share of common stock	$ 0.27	$ 0.93	$ 1.64	$ 2.70
Diluted net earnings per share of common stock	$ 0.27	$ 0.92	$ 1.62	$ 2.68
Weighted-average shares outstanding—in millions:
Basic	378.3	380.2	378.7	380.7
Net effect of dilutive employee stock options	3.4	2.3	3.1	2.5
Diluted	381.7	382.5	381.8	383.2
Anti-dilutive shares excluded from the calculation of net effect of dilutive employee stock options	0	6.4	1.9	8.6